Skip to Content

Medications for Cutaneous T-cell Lymphoma

Other names: Cancer, Cutaneous T-cell Lymphoma; CTCL; Lymphoma, Cutaneous T-cell Lymphoma

What is Cutaneous T-cell Lymphoma:  A type of non-Hodgkin's lymphoma that first appears on the skin.

Synonym: mycosis fungoides.

Medications to treat Cutaneous T-cell Lymphoma

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Targretin X N 2 reviews
9.0

Generic name: bexarotene systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Targretin Gel X N Add review Rate

Generic name: bexarotene topical

Drug class: miscellaneous topical agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
romidepsin D N Add review Rate

Generic name: romidepsin systemic

Brand name:  Istodax

Drug class: histone deacetylase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
vorinostat D N Add review Rate

Generic name: vorinostat systemic

Brand name:  Zolinza

Drug class: histone deacetylase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Zolinza D N Add review Rate

Generic name: vorinostat systemic

Drug class: histone deacetylase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Istodax D N Add review Rate

Generic name: romidepsin systemic

Drug class: histone deacetylase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Actimmune C N Add review Rate

Generic name: interferon gamma-1b systemic

Drug class: interferons

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Uvadex D N Add review Rate

Generic name: methoxsalen systemic

Drug class: psoralens

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
bexarotene X N 2 reviews
9.0

Generic name: bexarotene systemic

Brand name:  Targretin

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
8-MOP D N Add review Rate

Generic name: methoxsalen systemic

Drug class: psoralens

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
clobetasol Off Label C N Add review Rate

Generic name: clobetasol topical

Drug class: topical steroids

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
methoxsalen D N Add review Rate

Generic name: methoxsalen systemic

Brand names:  Uvadex, 8-MOP

Drug class: psoralens

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, Prescribing Information

 
interferon gamma-1b C N Add review Rate

Generic name: interferon gamma-1b systemic

Brand name:  Actimmune

Drug class: interferons

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
bexarotene X N Add review Rate

Generic name: bexarotene topical

Brand name:  Targretin Gel

Drug class: miscellaneous topical agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 

Topics under Cutaneous T-cell Lymphoma

Learn more about Cutaneous T-cell Lymphoma

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide